Genkyotex

Genkyotex is dedicated to developing innovative drugs that block enzymes responsible for generating oxygen free radicals. These novel drugs will enable the treatment of acute and chronic diseases mediated by oxygen free radicals with improved specificity, safety, and efficacy compared to existing antioxidant therapies, giving them a significant competitive advantage. Genkyotex initially applied its technology to therapeutic areas including cardiovascular, metabolic, and neurodegenerative diseases.